Oragenics OGEN
NYSE OGEN
$0.36 +0.00 (+0.92%)
As of: Nov 10, 2026 · 12:32 PM EST

Oragenics (OGEN) Convertible Debt (2010 - 2012)

Updated

Oragenics' Convertible Debt came in at $773,904 for Q1 2012.

Analysis

Oragenics (OGEN) Convertible Debt (2010 - 2012) Analysis & Trends

At the end of FY2010, Oragenics' Convertible Debt was $2 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Oragenics 1.59 Mn -28.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2012 773,904.00
Jun 30, 2011 4.50 Mn
Dec 31, 2010 2.00 Mn
API Access

Oragenics Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=OGEN&period=max&api_key=YOUR_API_KEY